National Cannabis Review

Linking the Marijuana Industry
Industry Links
         
Medical Links
     
Recreational
       

Colorado Marijuana Infused Products Producers (98)

Denver (1)



Arvada (1)



Aspen (1)



Aurora (2)



Bailey (1)



Boulder (6)



Breckenridge (2)



Carbondale (1)



Colorado Springs (9)



Commerce City (1)



Crested Butte (1)



De Beque (1)



Denver (50)



Edgewater (1)



Evergreen (1)



Frisco (1)



Garden City (1)



Georgetown (1)



Gunnison (1)



Log Lane Village (1)



Longmont (1)



Louisville (1)



Nederland (1)



Oak Creek (1)



Palmer Lake (1)



Pueblo West (2)



Pueblo (2)



Salida (1)



Steamboat Springs (1)



Telluride (1)



Trinidad (2)



Add a listing


National Cannabis Industry News    Search Industry News: 
The Oregonian | Nov 16 2018
 Oregon marijuana prices plunge and sales soar


Rampant overproduction in Oregons market for legal, recreational marijuana has produced a 50 percent decline in prices, according to state economists. That widely documented collapse has been hard on farmers and retailers but a boon for consumers. A new state analysis finds the price collapse sparked a big uptick in marijuana purchases and a corresponding increase in associated tax revenue. Lower prices are helping to drive the volume of sales higher and induce black and medical market conversions into the legal, recreational market, according to Josh Lehner of the Oreg....
View more in new window
Marijuana Policy Project | Nov 07, 2018
 Another election, and another historic night for marijuana reform


Michigan has passed legalization MPP played a central role in this campaign from start to finish. From coordinating the initiative drafting to overseeing the production of TV ads, MPP staffers worked alongside a excellent campaign team for two years to make Michigan the first state in the Midwest to adopt legalization. This is a huge win that will maintain our momentum in Washington, D.C. to pass a landmark federal reform bill through Congress in the near future. Utah passed medical marijuana MPP led the drafting process and played an important supporting role throughout t....
View more in new window
NORML | November 7, 2018
 Marijuana Reform Scores Big Wins In Midterms


Marijuana reformers enjoyed numerous federal, state, and local victories last night. Here are the highlights. STATE BALLOT INITIATIVES Florida: Sixty-three percent of Florida voters approved Amendment 4, which amends the state constitution to restore voting privileges to those with non-violent felony convictions including tens of thousands of those convicted of marijuana-related offenses. Passage of the amendment is anticipated to reinstate voting rights to some 1.4 million Floridians. Michigan: Voters by a margin of 56 percent to 44 percent approved Proposal 1, legaliz....
View more in new window
CANN Media Group | November 7, 2018
 Cannabis on the Ballot: What the Election Results Mean For Residents and Businesses


Danny Reed
November 6, 2018, may have resulted in a split decision for Republicans and Democrats, but cannabis emerged from the midterm election a clear winner. Voters in Missouri and Utah green-lighted medical programs, becoming the 31st and 32nd states to do so. Michigan voters turned their state into the 10thand the first in the Midwestto legalize recreational use. A long-shot measure to legalize recreational use in North Dakota failed. In Colorado, an amendment removing the definition of industrial hemp from the states constitution squeezed through with 61 percent of the vote. Ad....
View more in new window
Denver Post | Nov 1, 2018
 First cannabis-based medicine approved by FDA arrives in the U.S.
GW Pharmaceuticals Epidiolex, a medicine made from the marijuana plant but without THC. The medicine reduced seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday, April 17, 2018.
GW Pharmaceuticals Epidiolex, a medicine made from the marijuana plant but without THC. The medicine reduced seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday, April 17, 2018.
Jessica Seaman
For the first time, a marijuana-based medicine approved by federal regulators is available for prescription in the United States. The medicine, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological disorder, according to a news release. Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures, said Justin Gover, chief executive officer of GW Pharmaceuti....
View more in new window
Older cannabis industry news.
Home
Mission Statement
Privacy Statement
Rating System
Submit
Link Back
Contact Mark
© Copyright 2017-2017
We make every effort to provide timely and accurate information, however we cannot guaranty the accuracy of these listings.
To correct a listing, please use the corrections link or contact the web master, Mark.
This web site contains no advertising. Listings in this directory are licensed business.
Reviews and editorials are the opinion of the author only, not those of the National Cannabis Review.
No Sign In -- Minimum Digital Footprint
Reduce violence on the border, support local growers, keep your cash in your community, and get consistent quality Legalize It World Wide!.